Susquehanna International Group, LLP Armata Pharmaceuticals, Inc. Transaction History

Susquehanna International Group, LLP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$1.46 - $2.19 $32,276 - $48,414	-22,107 Reduced 44.4%	27,681 $40,000
Q4 2024 Feb 14, 2025	BUY	$1.85 - $2.82 $37,003 - $56,405	20,002 Added 67.15%	49,788 $92,000
Q3 2024 Nov 14, 2024	SELL	$2.1 - $3.3 $71,874 - $112,945	-34,226 Reduced 53.47%	29,786 $70,000
Q2 2024 Aug 15, 2024	SELL	$2.4 - $3.9 $57,098 - $92,784	-23,791 Reduced 27.1%	64,012 $176,000
Q1 2024 May 07, 2024	BUY	$2.81 - $4.18 $246,726 - $367,016	87,803 New	87,803 $367,000
Q4 2022 Feb 14, 2023	BUY	$0.94 - $4.16 $9,632 - $42,627	10,247 New	10,247 $12,000
Q1 2022 May 16, 2022	SELL	$3.9 - $6.32 $46,924 - $76,042	-12,032 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.96 - $5.86 $35,614 - $70,507	12,032 New	12,032 $66,000
Q1 2020 May 15, 2020	SELL	$2.58 - $4.85 $37,895 - $71,236	-14,688 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.16 - $4.54 $46,414 - $66,683	14,688 New	14,688 $48,000

730K

Ticker ARMP
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,144,700
Market Cap $177M
Description
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.